Submission of certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Novelix Pharmaceuticals Ltd has submitted a quarterly compliance certificate from its Registrar and Share Transfer Agent, Venture Capital and Corporate Investments Private Limited, for the quarter ended 30 June 2025. The certificate confirms that physical shares received for dematerialisation were properly mutilated and cancelled, and the depositories (NSDL and CDSL) were updated as the registered owners within the required 15-day window. The submission was signed by Whole-time Director Venkateshwarlu Pulluru and filed with BSE on 15 July 2025. This is a standard regulatory filing with no financial or business information disclosed.
This is a routine compliance filing with no material impact on the company's operations, financials, or stock price. It only confirms proper handling of share dematerialisation requests.